75 related articles for article (PubMed ID: 22396044)
21. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.
Zheng H; Liu Y; Deng Y; Li Y; Liu S; Yang Y; Qiu Y; Li B; Sheng W; Liu J; Peng C; Wang W; Yu H
Mol Med; 2024 Feb; 30(1):20. PubMed ID: 38310228
[TBL] [Abstract][Full Text] [Related]
22. The role of T-cell leukemia translocation-associated gene protein in human tumorigenesis and osteoclastogenesis.
Kotake S; Yago T; Kawamoto M; Nanke Y
J Biomed Biotechnol; 2012; 2012():675317. PubMed ID: 22174563
[TBL] [Abstract][Full Text] [Related]
23. A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.
Cheng CP; Huang HS; Hsu YC; Sheu MJ; Chang DM
J Clin Immunol; 2012 Aug; 32(4):762-77. PubMed ID: 22396044
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
25. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
27. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
Lee SY; Lee KS; Yi SH; Kook SH; Lee JC
PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641
[TBL] [Abstract][Full Text] [Related]
28. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.
Wei ZF; Tong B; Xia YF; Lu Q; Chou GX; Wang ZT; Dai Y
PLoS One; 2013; 8(3):e59171. PubMed ID: 23536866
[TBL] [Abstract][Full Text] [Related]
29. A benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.
Liu FC; Huang HS; Huang CY; Yang R; Chang DM; Lai JH; Ho LJ
J Clin Immunol; 2011 Dec; 31(6):1131-42. PubMed ID: 21858617
[TBL] [Abstract][Full Text] [Related]
30. Kinome profiling reveals an interaction between jasmonate, salicylate and light control of hyponastic petiole growth in Arabidopsis thaliana.
Ritsema T; van Zanten M; Leon-Reyes A; Voesenek LA; Millenaar FF; Pieterse CM; Peeters AJ
PLoS One; 2010 Dec; 5(12):e14255. PubMed ID: 21170386
[TBL] [Abstract][Full Text] [Related]
31. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.
Ang ES; Pavlos NJ; Chai LY; Qi M; Cheng TS; Steer JH; Joyce DA; Zheng MH; Xu J
J Cell Physiol; 2009 Dec; 221(3):642-9. PubMed ID: 19681045
[TBL] [Abstract][Full Text] [Related]
32. IL-23 induces receptor activator of NF-kappaB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model.
Ju JH; Cho ML; Moon YM; Oh HJ; Park JS; Jhun JY; Min SY; Cho YG; Park KS; Yoon CH; Min JK; Park SH; Sung YC; Kim HY
J Immunol; 2008 Jul; 181(2):1507-18. PubMed ID: 18606706
[TBL] [Abstract][Full Text] [Related]
33. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
[TBL] [Abstract][Full Text] [Related]
34. Amplifying elements of arthritis and joint destruction.
van den Berg WB; van Lent PL; Joosten LA; Abdollahi-Roodsaz S; Koenders MI
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii45-8. PubMed ID: 17934095
[TBL] [Abstract][Full Text] [Related]
35. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.
Mozar A; Haren N; Chasseraud M; Louvet L; Mazière C; Wattel A; Mentaverri R; Morlière P; Kamel S; Brazier M; Mazière JC; Massy ZA
J Cell Physiol; 2008 Apr; 215(1):47-54. PubMed ID: 17894387
[TBL] [Abstract][Full Text] [Related]
36. The immunology of rheumatoid arthritis.
Scrivo R; Di Franco M; Spadaro A; Valesini G
Ann N Y Acad Sci; 2007 Jun; 1108():312-22. PubMed ID: 17893995
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF
J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
